2024-04-01 2025-03-31 2025-03-31 false 11500228 JSK SURGERY LIMITED 2025-11-05 false iso4217:GBP xbrli:pure 11500228 2024-03-31 11500228 2025-03-31 11500228 2024-04-01 2025-03-31 11500228 2023-03-31 11500228 2024-03-31 11500228 2023-04-01 2024-03-31 11500228 bus:SmallEntities 2024-04-01 2025-03-31 11500228 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11500228 bus:FullAccounts 2024-04-01 2025-03-31 11500228 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11500228 core:WithinOneYear 2025-03-31 11500228 core:AfterOneYear 2025-03-31 11500228 core:WithinOneYear 2024-03-31 11500228 core:AfterOneYear 2024-03-31 11500228 core:ShareCapital 2025-03-31 11500228 core:SharePremium 2025-03-31 11500228 core:RevaluationReserve 2025-03-31 11500228 core:OtherReservesSubtotal 2025-03-31 11500228 core:RetainedEarningsAccumulatedLosses 2025-03-31 11500228 core:ShareCapital 2024-03-31 11500228 core:SharePremium 2024-03-31 11500228 core:RevaluationReserve 2024-03-31 11500228 core:OtherReservesSubtotal 2024-03-31 11500228 core:RetainedEarningsAccumulatedLosses 2024-03-31 11500228 core:LandBuildings 2025-03-31 11500228 core:PlantMachinery 2025-03-31 11500228 core:Vehicles 2025-03-31 11500228 core:FurnitureFittings 2025-03-31 11500228 core:OfficeEquipment 2025-03-31 11500228 core:NetGoodwill 2025-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 11500228 core:ListedExchangeTraded 2025-03-31 11500228 core:UnlistedNon-exchangeTraded 2025-03-31 11500228 core:LandBuildings 2024-03-31 11500228 core:PlantMachinery 2024-03-31 11500228 core:Vehicles 2024-03-31 11500228 core:FurnitureFittings 2024-03-31 11500228 core:OfficeEquipment 2024-03-31 11500228 core:NetGoodwill 2024-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 11500228 core:ListedExchangeTraded 2024-03-31 11500228 core:UnlistedNon-exchangeTraded 2024-03-31 11500228 core:LandBuildings 2024-04-01 2025-03-31 11500228 core:PlantMachinery 2024-04-01 2025-03-31 11500228 core:Vehicles 2024-04-01 2025-03-31 11500228 core:FurnitureFittings 2024-04-01 2025-03-31 11500228 core:OfficeEquipment 2024-04-01 2025-03-31 11500228 core:NetGoodwill 2024-04-01 2025-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 11500228 core:ListedExchangeTraded 2024-04-01 2025-03-31 11500228 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 11500228 core:MoreThanFiveYears 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments 2025-03-31 11500228 core:Non-currentFinancialInstruments 2024-03-31 11500228 dpl:CostSales 2024-04-01 2025-03-31 11500228 dpl:DistributionCosts 2024-04-01 2025-03-31 11500228 core:LandBuildings 2024-04-01 2025-03-31 11500228 core:PlantMachinery 2024-04-01 2025-03-31 11500228 core:Vehicles 2024-04-01 2025-03-31 11500228 core:FurnitureFittings 2024-04-01 2025-03-31 11500228 core:OfficeEquipment 2024-04-01 2025-03-31 11500228 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 11500228 core:NetGoodwill 2024-04-01 2025-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 11500228 dpl:GroupUndertakings 2024-04-01 2025-03-31 11500228 dpl:ParticipatingInterests 2024-04-01 2025-03-31 11500228 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 11500228 core:ListedExchangeTraded 2024-04-01 2025-03-31 11500228 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 11500228 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 11500228 dpl:CostSales 2023-04-01 2024-03-31 11500228 dpl:DistributionCosts 2023-04-01 2024-03-31 11500228 core:LandBuildings 2023-04-01 2024-03-31 11500228 core:PlantMachinery 2023-04-01 2024-03-31 11500228 core:Vehicles 2023-04-01 2024-03-31 11500228 core:FurnitureFittings 2023-04-01 2024-03-31 11500228 core:OfficeEquipment 2023-04-01 2024-03-31 11500228 dpl:AdministrativeExpenses 2023-04-01 2024-03-31 11500228 core:NetGoodwill 2023-04-01 2024-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 11500228 dpl:GroupUndertakings 2023-04-01 2024-03-31 11500228 dpl:ParticipatingInterests 2023-04-01 2024-03-31 11500228 dpl:GroupUndertakings core:ListedExchangeTraded 2023-04-01 2024-03-31 11500228 core:ListedExchangeTraded 2023-04-01 2024-03-31 11500228 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 11500228 core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 11500228 core:NetGoodwill 2025-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 11500228 core:LandBuildings 2025-03-31 11500228 core:PlantMachinery 2025-03-31 11500228 core:Vehicles 2025-03-31 11500228 core:FurnitureFittings 2025-03-31 11500228 core:OfficeEquipment 2025-03-31 11500228 core:AfterOneYear 2025-03-31 11500228 core:WithinOneYear 2025-03-31 11500228 core:ListedExchangeTraded 2025-03-31 11500228 core:UnlistedNon-exchangeTraded 2025-03-31 11500228 core:ShareCapital 2025-03-31 11500228 core:SharePremium 2025-03-31 11500228 core:RevaluationReserve 2025-03-31 11500228 core:OtherReservesSubtotal 2025-03-31 11500228 core:RetainedEarningsAccumulatedLosses 2025-03-31 11500228 core:NetGoodwill 2024-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 11500228 core:LandBuildings 2024-03-31 11500228 core:PlantMachinery 2024-03-31 11500228 core:Vehicles 2024-03-31 11500228 core:FurnitureFittings 2024-03-31 11500228 core:OfficeEquipment 2024-03-31 11500228 core:AfterOneYear 2024-03-31 11500228 core:WithinOneYear 2024-03-31 11500228 core:ListedExchangeTraded 2024-03-31 11500228 core:UnlistedNon-exchangeTraded 2024-03-31 11500228 core:ShareCapital 2024-03-31 11500228 core:SharePremium 2024-03-31 11500228 core:RevaluationReserve 2024-03-31 11500228 core:OtherReservesSubtotal 2024-03-31 11500228 core:RetainedEarningsAccumulatedLosses 2024-03-31 11500228 core:NetGoodwill 2023-03-31 11500228 core:IntangibleAssetsOtherThanGoodwill 2023-03-31 11500228 core:LandBuildings 2023-03-31 11500228 core:PlantMachinery 2023-03-31 11500228 core:Vehicles 2023-03-31 11500228 core:FurnitureFittings 2023-03-31 11500228 core:OfficeEquipment 2023-03-31 11500228 core:AfterOneYear 2023-03-31 11500228 core:WithinOneYear 2023-03-31 11500228 core:ListedExchangeTraded 2023-03-31 11500228 core:UnlistedNon-exchangeTraded 2023-03-31 11500228 core:ShareCapital 2023-03-31 11500228 core:SharePremium 2023-03-31 11500228 core:RevaluationReserve 2023-03-31 11500228 core:OtherReservesSubtotal 2023-03-31 11500228 core:RetainedEarningsAccumulatedLosses 2023-03-31 11500228 core:AfterOneYear 2024-04-01 2025-03-31 11500228 core:WithinOneYear 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:CostValuation 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 11500228 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 11500228 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 11500228 core:Non-currentFinancialInstruments core:CostValuation 2024-03-31 11500228 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-31 11500228 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-31 11500228 bus:Director1 2024-04-01 2025-03-31 11500228 bus:Director2 2024-04-01 2025-03-31

JSK SURGERY LIMITED

Registered Number
11500228
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

JSK SURGERY LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors | KNIGHT, John Sebastian
| KNIGHT, Kate Sunita, Dr

Registered Address | 1st Floor, Buckley House 31a The Hundred
| Romsey
| SO51 8GD

Registered Number | 11500228 (England and Wales)

JSK SURGERY LIMITED
Balance Sheet as at
31 March 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 75,063 |  |  |  | 38,303
|  |  |  | 75,063 |  |  |  | 38,303
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 814 |  |  |  | 2,047 |  |
Cash at bank and on hand |  | 35,758 |  |  |  | 29,418 |  |
|  | 36,572 |  |  |  | 31,465 |  |
Creditors amounts falling due within one year | 5 | (13,951) |  |  |  | (5,271) |  |
Net current assets (liabilities) |  |  |  | 22,621 |  |  |  | 26,194
Total assets less current liabilities |  |  |  | 97,684 |  |  |  | 64,497
Creditors amounts falling due after one year | 6 |  |  | (46,468) |  |  |  | -
Net assets |  |  |  | 51,216 |  |  |  | 64,497
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 150 |  |  |  | 150
Profit and loss account |  |  |  | 51,066 |  |  |  | 64,347
Shareholders' funds |  |  |  | 51,216 |  |  |  | 64,497

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 5 November 2025, and are signed on its behalf by:
KNIGHT, John Sebastian Director Registered Company No. 11500228

JSK SURGERY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Current taxation
--- | ---
| Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%)
| Plant and machinery | 25
| Vehicles | 25
| Office Equipment | 50

| Finance leases and hire purchase contracts
--- | ---
| Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 2 |  | 2

3. | Tangible fixed assets
--- | ---

|  | Plant & machinery |  | Vehicles |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
| Cost or valuation
| At 01 April 24 | 3,811 |  | 59,990 |  | 9,939 |  | 73,740
| Additions | 2,700 |  | 82,900 |  | 1,512 |  | 87,112
| Disposals | - |  | (59,990) |  | - |  | (59,990)
| At 31 March 25 | 6,511 |  | 82,900 |  | 11,451 |  | 100,862
| Depreciation and impairment
| At 01 April 24 | 953 |  | 26,246 |  | 8,238 |  | 35,437
| Charge for year | 608 |  | 15,842 |  | 158 |  | 16,608
| On disposals | - |  | (26,246) |  | - |  | (26,246)
| At 31 March 25 | 1,561 |  | 15,842 |  | 8,396 |  | 25,799
| Net book value
| At 31 March 25 | 4,950 |  | 67,058 |  | 3,055 |  | 75,063
| At 31 March 24 | 2,858 |  | 33,744 |  | 1,701 |  | 38,303

4. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 814 |  | 2,047
| Total | 814 |  | 2,047

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | - |  | 210
| Taxation and social security | 5,025 |  | 3,075
| Finance lease and HP contracts | 7,231 |  | -
| Other creditors | 135 |  | 127
| Accrued liabilities and deferred income | 1,560 |  | 1,859
| Total | 13,951 |  | 5,271

6. | Creditors: amounts due after one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other creditors | 46,468 |  | -
| Total | 46,468 |  | -

7. | Obligations under finance leases
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Finance lease and HP contracts | 53,700 |  | -